Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Refresh Optive Advanced is a lipid-enhanced lubricant eye drop formulated to relieve dry, burning, and irritated eyes. It features a triple-action formula that lubricates for moisturizing relief, hydrates the eye surface cells, and protects natural tears by reducing tear evaporation. The product supports all three layers of the tear film and is available in both preservative-free single-use vials and multi-dose bottles. Its primary active ingredients are carboxymethylcellulose sodium (0.5%), glycerin (0.9%), and polysorbate 80; these work together to provide temporary relief from symptoms of dry eye due to environmental factors or insufficient tear production[1][2][3][4][5][8]. The mechanism of action is physical lubrication and stabilization of the tear film rather than pharmacological modulation. **Developers:** Allergan **Manufacturers:** Allergan
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on carboxymethylcellulose sodium + glycerin + polysorbate 80 (Allergan).